{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T14:13:27Z","timestamp":1742393607449,"version":"3.38.0"},"reference-count":69,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Chirurgica Belgica"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1080\/00015458.2002.11679274","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T13:44:07Z","timestamp":1462369447000},"page":"97-109","source":"Crossref","is-referenced-by-count":4,"title":["New Challenges in the Treatment of Early Breast Cancer or Surgery for Early Breast Cancer... Can Less be More?"],"prefix":"10.1080","volume":"102","author":[{"given":"M.","family":"Meurisse","sequence":"first","affiliation":[{"name":"Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Li\u00e8ge, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Defechereux","sequence":"additional","affiliation":[{"name":"Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Li\u00e8ge, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Meurisse","sequence":"additional","affiliation":[{"name":"Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Li\u00e8ge, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Bataille","sequence":"additional","affiliation":[{"name":"Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Li\u00e8ge, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hamoir","sequence":"additional","affiliation":[{"name":"Department of Endocrine, Breast and Transplant Surgery, Centre Hospitalier Universitaire du Sart Tilman, Li\u00e8ge, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"Bonadonna G. Evolving concepts in the systemic adjuvant treatment of breast cancer. Cancer Res 1992 52: 2127\u20132137."},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Karrison T. G. Ferguson D. J. Meier P. Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 1999 91: 80\u201385.","DOI":"10.1093\/jnci\/91.1.80"},{"key":"e_1_2_1_4_1","unstructured":"Fisher B. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res 1992 52 (12): 3512."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Schmidt J. E. Natural history of breast cancer (letter). Lancet 1992 339: 810.","DOI":"10.1016\/0140-6736(92)91937-4"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"Kerlikowske K. Grady D. Rubin S. M. Efficacy of screening mammography: A meta-analysis. JAMA 1995 273: 149\u2013154.","DOI":"10.1001\/jama.1995.03520260071035"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Hendrick R. E. Smith R. A. Rutledge J. H. Benefit of screening mammography in women age 40\u201349: A new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997 22: 87\u201392.","DOI":"10.1093\/jncimono\/1997.22.87"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Baines C. J. Miller A. B. Mammography versus clinical examination of the breasts. Monogr Natl Cancer Inst 1997 22: 125\u2013129.","DOI":"10.1093\/jncimono\/1997.22.125"},{"key":"e_1_2_1_9_1","unstructured":"Miller A. B. Baines C. J. To T. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40\u201349 years. Can Med Assoc J 1992 147: 1459\u20131476."},{"key":"e_1_2_1_10_1","unstructured":"Miller A. B. Baines C. J. To T. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 50\u201359 years. Can Med Assoc J 1992 147: 1477\u20131488."},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Van Netten J. P. Russ A. S. Cann S. A. Is breast cancer a progressive or systemic disease (letter). Lancet 1995 345: 319\u2013320.","DOI":"10.1016\/S0140-6736(95)90308-9"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Gamel J. W. Edwards M. J. Parametric models of therapeutic efficacy in breast cancer (letter). N Engl J Med 1996 344: 1270\u20131271.","DOI":"10.1056\/NEJM199605093341913"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"Tabar L. Fagerberg G. Day N. E. What is the optimum interval between mammographic screening examinations ? An analysis based on the latest results of the Swedish Two-County Breast cancer screening trial. Br J Cancer 1987 55: 547\u2013551.","DOI":"10.1038\/bjc.1987.112"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Mandelblatt J. S. Wheat M. E. Monane M. Breast cancer screening for elderly women with and without comorbid conditions: A decision analysis model. Ann Intern Med 1992 116: 722\u2013730.","DOI":"10.7326\/0003-4819-116-9-722"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Faulk R. M. Sickles E. A. Sollitto R. A. Clinical efficacy of mammographic screening in the elderly. Radiology 1995 194: 193\u2013197.","DOI":"10.1148\/radiology.194.1.7997552"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","unstructured":"Yancik R. Ries L. G. Yates J. W. Breast cancer in aging women: A population-based study of contrasts in stage surgery and survival. Cancer 1989 63: 976\u2013981.","DOI":"10.1002\/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Welch H. G. Albertsen P. C. Nease R. F. Estimating treatment benefits for the elderly: The effect of competing risks. Ann Intern Med 1996 124: 577\u2013584.","DOI":"10.7326\/0003-4819-124-6-199603150-00007"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Tabar L. Fagerberg G. Day N. E. Efficacy of breast cancer screening by age: New results from the Swedish Two-County trial. Cancer 1995 75: 2507\u20132517.","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Kerlikowske K. Grady D. Barclay J. Effect of age breast density and family history on the sensitivity of first screening mam-mography. JAMA 1996 276: 33\u201338.","DOI":"10.1001\/jama.1996.03540010035027"},{"key":"e_1_2_1_20_1","unstructured":"Shapiro S. Venet W. Strax P. Ten-to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982 69: 349\u2013355."},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Drew P. J. Turnbull L. W. Chatterjee S. Read J. Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions. Ann Surg 1999 230: 680\u2013685.","DOI":"10.1097\/00000658-199911000-00010"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","unstructured":"Kinkel K. Helbich T. H. Esserman L. J. Barclay J. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol 2000 175: 35\u201343.","DOI":"10.2214\/ajr.175.1.1750035"},{"key":"e_1_2_1_23_1","unstructured":"Van Ongeval C. MR imaging of the breast present indications. JBR-BTR 2000 83: 80\u201384."},{"key":"e_1_2_1_24_1","unstructured":"Enright A. Magnetic resonance spectroscopy. Cancer Forum 2000 24: 210\u2013212."},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Kvistad K. A. Bakken I. J. Gribbestad I. S. Ehrnholm B. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999 10: 159\u2013164.","DOI":"10.1002\/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0"},{"key":"e_1_2_1_26_1","unstructured":"Khalkhali I. Villanueva-Meyer J. Edell S. L. Connolly J. L. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med 2000 41: 1973\u20131979."},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","unstructured":"Wong A. Y. Salisbury E. Bilous M. Recent developments in stereotactic breast biopsy methodologies: an update for the surgical pathologist. Adv Anat Pathol 2000 7 (1): 26\u201335.","DOI":"10.1097\/00125480-200007010-00005"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Pisano E. D. Yaffe M. J. Hemminger B. M. Hendrick R. E. Niklason L. T. Maidment A. D. Current status of full-field digital mammography. Acad Radiol 2000 7 (4): 266\u2013280.","DOI":"10.1016\/S1076-6332(00)80478-X"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Fisher B. Anderson S. Redmond C. K. Reanalysis and resukts after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995 333: 1456\u20131461.","DOI":"10.1056\/NEJM199511303332203"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"Veronesi U. Salvadori B. Luini A. Breast conservation is a safe method in patients with small cancers of the breast. Long-term results of threee randomized trials on 1973 patients. Eur J Cancer 1995 31A: 1574\u20131579.","DOI":"10.1016\/0959-8049(95)00271-J"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","unstructured":"Abner A. Gelman R. Connolly J. The relationship between microscopic margins of resection and the risk of llocal recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994 74: 1746\u20131751.","DOI":"10.1002\/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO;2-Y"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Kroll S. S. Schusterman M. A. Tadjalli H. E. Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy. Ann Surg Oncol 1998 4: 193\u2013197.","DOI":"10.1007\/BF02306609"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","unstructured":"Fisher B. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 1995 13: 537\u2013540.","DOI":"10.1200\/JCO.1995.13.3.537"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","unstructured":"Fisher B. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel project B-18. J Clin Oncol 1997 15: 2483\u20132493.","DOI":"10.1200\/JCO.1997.15.7.2483"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","unstructured":"Fisher B. Anderson S. Fisher E. R. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991 338 (8763): 327\u2013331.","DOI":"10.1016\/0140-6736(91)90475-5"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","unstructured":"Rose M. A. Henderson I. C. Gelman R. et al. Premenopausal breast cancer patients treated with conservative surgery radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 1989 17: 711\u2013717.","DOI":"10.1016\/0360-3016(89)90056-4"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","unstructured":"Lacour J. Bucalossi P. Cacers E. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 1976 37: 206\u2013214.","DOI":"10.1002\/1097-0142(197601)37:1<206::AID-CNCR2820370130>3.0.CO;2-M"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","unstructured":"Lin P. P. Allison D. C. Wainstock J. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993 11 (8): 1536\u20131544.","DOI":"10.1200\/JCO.1993.11.8.1536"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","unstructured":"Giuliano A. E. Kirgan D. M. Guenther J. M. Lymphatic mapping and sentinel lymphadenomectomy for breast cancer. Ann Surg 1994 220 (3): 391\u2013401.","DOI":"10.1097\/00000658-199409000-00015"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","unstructured":"Cabanas R. M. An approach for the treatment of penile carcinoma. Cancer 1977 39: 456\u2013466.","DOI":"10.1002\/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","unstructured":"Morton D. L. Wen D. R. Wong J. H. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 127: 392\u2013399.","DOI":"10.1001\/archsurg.1992.01420040034005"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","unstructured":"Krag D. Weaver D. Ashikaga T. The sentinel node in breast cancer. N Engl J Med 1998 339: 941\u2013946.","DOI":"10.1056\/NEJM199810013391401"},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","unstructured":"Giuliano A. E. Dale P. S. Turner R. R. Improved axillary staging of breast cancer with sentinel lymph node lymphadenectomy. Ann Surg 1995 222: 394\u2013399.","DOI":"10.1097\/00000658-199509000-00016"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","unstructured":"Quiet C. A. Ferguson D. J. Weichselbaum R. R. Natural history of node-negative breast cancer: A study of 826 patients with longterm follow-up. J Clin Oncol 1995 13: 1144\u20131151.","DOI":"10.1200\/JCO.1995.13.5.1144"},{"key":"e_1_2_1_45_1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998 351 (9114): 1451\u20131467.","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Polychemo-therapy for early breast cancer: an overview of the randomised trials. Lancet 1998 352 (9132): 930\u2013942.","DOI":"10.1016\/S0140-6736(98)03301-7"},{"key":"e_1_2_1_47_1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28 896 women. N Engl J Med 1988 319 (26): 1681\u20131692.","DOI":"10.1056\/NEJM198812293192601"},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992 339 (8785): 71\u201385.","DOI":"10.1016\/0140-6736(92)90139-T"},{"key":"e_1_2_1_49_1","doi-asserted-by":"crossref","unstructured":"Goldhirsh A. Glick J. H. Gelber R. D. Meeting highlights: international Consensus Panel on the treatment of primary breast cancer. J Natl Cancer Inst 1998 90: 1601\u20131608.","DOI":"10.1093\/jnci\/90.21.1601"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","unstructured":"Wood W. C. Budman D. R. Korzun A. H. Dose and dose intensity of adjuvant chemotherapy for stage ii node-positive breast carcinomas. N Engl J Med 1994 330: 1253\u20131259.","DOI":"10.1056\/NEJM199405053301801"},{"key":"e_1_2_1_51_1","doi-asserted-by":"crossref","unstructured":"Thor A. D. Berry D. A. Budman D. R. erbB-2 p53 and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst 1998 90: 1346\u20131360.","DOI":"10.1093\/jnci\/90.18.1346"},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","unstructured":"Hryniuk W. Levine M. N. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol 1986 4: 1162\u20131170.","DOI":"10.1200\/JCO.1986.4.8.1162"},{"key":"e_1_2_1_53_1","doi-asserted-by":"crossref","unstructured":"Gusterson B. A. Gelber R. D. Goldhirsh A. Prognostic importance of cerbB-2 expression in breast cancer. J Clin Oncol 1992 10: 1049\u20131056.","DOI":"10.1200\/JCO.1992.10.7.1049"},{"key":"e_1_2_1_54_1","unstructured":"Slamon D. Leyland-Jones B. Shak S. Addition of herceptin (Humanized anti HER 2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer markedly increase anticancer activity: a randomized multinational controlled phase III trial. Proceedings of the American Society of Clinical Oncology 1998 17: 377A."},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","unstructured":"Offit K. Brown K. Quantitative familial cancer risk: a resource for clinical oncologists. J Clin Oncol 1994 12: 1724\u20131730.","DOI":"10.1200\/JCO.1994.12.8.1724"},{"key":"e_1_2_1_56_1","unstructured":"Claus E. B. Risch N. J. Thompson W. D. Genetic analysis of breast cancer in the cancer and steroids hormone study. Am J Hum Genet 1991 48: 232\u2013237."},{"key":"e_1_2_1_57_1","unstructured":"Easton D. B. Bishop D. T. Ford D. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 1993 52: 678\u2013683."},{"key":"e_1_2_1_58_1","doi-asserted-by":"crossref","unstructured":"Hall J. M. Lee M. K. Newman B. Linkage of early onset familial breast cancer to chromosome 17q21. Nature 1990 250: 1684\u20131688.","DOI":"10.1126\/science.2270482"},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","unstructured":"Wooster R. Neuhausen S. Mangion J. Localization of breast cancer susceptibility gene BRCA2 to chromosome 13q12\u201313. Science 1994 265: 2088\u20132091.","DOI":"10.1126\/science.8091231"},{"key":"e_1_2_1_60_1","unstructured":"Ford D. Easton D. B. Stratton M. Breast cancer linkage consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998 62: 676\u2013681."},{"key":"e_1_2_1_61_1","doi-asserted-by":"crossref","unstructured":"Zhang H. Tombline G. Weger B. BRCA1 BRCA2 and response: Collision or collusion. Cell 1998 92: 433\u2013437.","DOI":"10.1016\/S0092-8674(00)80936-8"},{"key":"e_1_2_1_62_1","doi-asserted-by":"crossref","unstructured":"Easton D. B. Breats cancr genes: what are the real risks ? Nat Genet 1997 16: 210\u2013217.","DOI":"10.1038\/ng0797-210"},{"key":"e_1_2_1_63_1","doi-asserted-by":"crossref","unstructured":"Robson M. Gilewski T. Haas B. BRCA-associated breast cancer in young women. J Clin Oncol 1998 16: 1642\u20131648.","DOI":"10.1200\/JCO.1998.16.5.1642"},{"key":"e_1_2_1_64_1","doi-asserted-by":"crossref","unstructured":"Lerman C. Schwartz M. Adherence and psychological adjuste-ment among women at high risk for breast cancer. Breats Cancer Res Treat 1993 28: 145\u2013155.","DOI":"10.1007\/BF00666427"},{"key":"e_1_2_1_65_1","doi-asserted-by":"crossref","unstructured":"Harms S. E. Breast magnetic resonance imaging. Semin Ultrasound CT MR 1998 19: 104\u2013120.","DOI":"10.1016\/S0887-2171(98)90027-0"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","unstructured":"Hartmann L. C. Schaid D. J. Woods J. E. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999 340: 77\u201384.","DOI":"10.1056\/NEJM199901143400201"},{"key":"e_1_2_1_67_1","unstructured":"Rebbeck T. Levin A. Daly M. Cancer risk reduction by prophylactic surgery in BRCA1 and BRCA2 mutation carriers (Abstract). Am J Hum Genet 1998 63: A47."},{"key":"e_1_2_1_68_1","doi-asserted-by":"crossref","unstructured":"Osborne M. P. Hormonal intervention in breast cancer: Past present and future. N Y Acad Sci 1996 784: 427\u2013432.","DOI":"10.1111\/j.1749-6632.1996.tb16257.x"},{"key":"e_1_2_1_69_1","doi-asserted-by":"crossref","unstructured":"Fisher B. Constantino J. P. Wickerham D. L. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998 90: 1371\u20131388.","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"e_1_2_1_70_1","unstructured":"Jordan V. C. Glusman J. E. Eckert S. Incident primary breast cancers are reduced by raloxifene: integrated data from multicenter double blind randomized trials in 12000 postmenopausal women (Abstract). Proceedings of the American Society of Clinical Oncology 1998 17: 122A."}],"container-title":["Acta Chirurgica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00015458.2002.11679274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:13:17Z","timestamp":1741882397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00015458.2002.11679274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1080\/00015458.2002.11679274"],"URL":"https:\/\/doi.org\/10.1080\/00015458.2002.11679274","relation":{},"ISSN":["0001-5458","2577-0160"],"issn-type":[{"type":"print","value":"0001-5458"},{"type":"electronic","value":"2577-0160"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}